BOK Financial’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-42,116
Closed -$4.18M 970
2019
Q3
$4.18M Buy
42,116
+9,565
+29% +$909K 0.1% 215
2019
Q2
$3.01M Sell
32,551
-6,243
-16% -$593K 0.07% 272
2019
Q1
$3.66M Sell
38,794
-3,358
-8% -$294K 0.09% 243
2018
Q4
$2.7M Sell
42,152
-25,736
-38% -$1.9M 0.08% 259
2018
Q3
$6.08M Sell
67,888
-1,291
-2% -$114K 0.15% 174
2018
Q2
$5.5M Sell
69,179
-13,511
-16% -$1.12M 0.15% 166
2018
Q1
$7.38M Sell
82,690
-15,269
-16% -$1.47M 0.21% 122
2017
Q4
$10.2M Buy
97,959
+11,972
+14% +$1.35M 0.28% 86
2017
Q3
$12.5M Sell
85,987
-985
-1% -$134K 0.36% 69
2017
Q2
$11.3M Sell
86,972
-3,279
-4% -$402K 0.36% 71
2017
Q1
$11.2M Sell
90,251
-8,220
-8% -$984K 0.35% 73
2016
Q4
$11.4M Sell
98,471
-17,690
-15% -$1.97M 0.38% 67
2016
Q3
$12.1M Sell
116,161
-353
-0.3% -$38.2K 0.4% 61
2016
Q2
$11.5M Sell
116,514
-10,731
-8% -$1.11M 0.4% 60
2016
Q1
$12.7M Sell
127,245
-13,234
-9% -$1.36M 0.46% 50
2015
Q4
$16.8M Sell
140,479
-13,260
-9% -$1.53M 0.61% 28
2015
Q3
$16.6M Sell
153,739
-8,697
-5% -$1.08M 0.63% 30
2015
Q2
$18.8M Sell
162,436
-22,244
-12% -$2.54M 0.64% 29
2015
Q1
$21.3M Buy
184,680
+26,139
+16% +$3.12M 0.72% 23
2014
Q4
$17.7M Buy
158,541
+9,059
+6% +$955K 0.61% 35
2014
Q3
$14.2M Sell
149,482
-9,111
-6% -$822K 0.47% 39
2014
Q2
$13.6M Sell
158,593
-8,441
-5% -$642K 0.44% 41
2014
Q1
$11.7M Buy
167,034
+14,064
+9% +$1.11M 0.39% 51
2013
Q4
$12.9M Sell
152,970
-27,780
-15% -$2.2M 0.43% 42
2013
Q3
$13.9M Sell
180,750
-37,804
-17% -$2.65M 0.51% 40
2013
Q2
$12.8M Buy
+218,554
New +$13.2M 0.48% 46

Other funds holding CELG

BOK Financial's CELG Position: Q4 2019 in Review

BOK Financial sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 42,116 shares — an estimated $4.18M sold.

BOK Financial first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $21.3M in Q1 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • BOK Financial reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • BOK Financial sold 42,116 Celgene Corp shares in Q4 2019, an estimated $4.18M.
  • BOK Financial first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • BOK Financial's Celgene Corp position peaked at $21.3M in Q1 2015.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on BOK Financial's 13F filing for Q4 2019, filed 12 Feb 2020.